Skip to main content
Log in

Magnificamide Is a New Effective Mammalian α-Amylase Inhibitor

  • BIOCHEMISTRY, BIOPHYSICS, AND MOLECULAR BIOLOGY
  • Published:
Doklady Biochemistry and Biophysics Aims and scope Submit manuscript

Abstract

Recombinant analogue of the sea anemone Heteractismagnifica peptide was obtained, and the kinetic parameters of its interaction with mammalian α-amylases were determined. Magnificamide inhibits α-amylases significantly stronger than the medical drug acarbose (PrecoseTM or GlucobayTM). Magnificamide is assumed to find application as a drug for prevention and treatment of metabolic disorders and type 2 diabetes mellitus.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1.
Fig. 2.
Fig. 3.

Similar content being viewed by others

REFERENCES

  1. Alam, U., Asghar, O., and Azmi, S., Handbook. Clin. Neurol., 2014, vol. 126, pp. 211–222.

    Article  Google Scholar 

  2. Pandey, A., Chawla, S., and Guchhait, P., IUBMB Life, 2015, vol. 67, pp. 506–513.

    Article  CAS  Google Scholar 

  3. Aye, T. and Levitsky, L.L., Curr. Opin. Pediatr., 2003, vol. 15, pp. 411–415.

    Article  Google Scholar 

  4. Trandafir, L.M. and Purcarea, M.R., J. Med. Life, 2016, vol. 9, pp. 235–239.

    PubMed  PubMed Central  Google Scholar 

  5. Scheen, A.J., Drugs, 2003, vol. 63, pp. 933–951.

    Article  CAS  Google Scholar 

  6. Chiasson, J.-L., Josse, R.G., Gomis, R., et al., Lancet, 2002, vol. 359, pp. 2072–2077.

    Article  CAS  Google Scholar 

  7. Wu, H., Liu, J., Lou, Q., et al., Medicine (Baltimore), 2017, vol. 96, p. 7533.

    Article  Google Scholar 

  8. Fosgerau, K. and Hoffmann, T., Drug Discov. Today, 2015, vol. 20, pp. 122–128.

    Article  CAS  Google Scholar 

  9. Sintsova, O., Gladkikh, I., Chausova, V., et al., J. Proteomics, 2018, vol. 173, pp. 12–21.

    Article  CAS  Google Scholar 

  10. Sintsova, O.V., Monastyrnaya, M.M., Pislyagin, E.A., et al., Russ. J. Bioorg. Chem., 2015, vol. 41, pp. 590–596.

    Article  CAS  Google Scholar 

  11. Monastyrnaya, M., Peigneur, S., Zelepuga, E., et al., Mar. Drugs, 2016, vol. 14, p. 229.

    Article  Google Scholar 

  12. Morrison, J.F., Biochim. Biophys. Acta—Enzymology, 1969, vol. 185, pp. 269–286.

    Article  CAS  Google Scholar 

  13. Yoon, S.H. and Robyt, J.F., Carbohydr. Res., 2003, vol. 338, pp. 1969–1980.

    Article  CAS  Google Scholar 

Download references

ACKNOWLEDGMENTS

Molecular weights of the peptides were determined using the equipment of the Far Eastern Center of Molecular Structural Studies (NMR and mass spectrometry) of the Pacific Institute of Bioorganic Chemistry, Far Eastern Branch, Russian Academy of Sciences.

Funding

This work was supported by the Russian Foundation for Basic Research (project no. 18-38-00389 (preparation of recombinant peptide and determination of Ki)).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to O. V. Sintsova.

Ethics declarations

The authors declare that they have no conflict of interest. This article does not contain any studies involving animals or human participants performed by any of the authors.

Additional information

Translated by M. Batrukova

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sintsova, O.V., Leychenko, E.V., Gladkikh, I.N. et al. Magnificamide Is a New Effective Mammalian α-Amylase Inhibitor. Dokl Biochem Biophys 489, 385–387 (2019). https://doi.org/10.1134/S1607672919060097

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1134/S1607672919060097

Navigation